Paul Tudor Jones's ANAB Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 4,962 shares of AnaptysBio, Inc. (ANAB) worth $275,193, representing 0.00% of the portfolio. First purchased in 2019-Q3, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in ANAB, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 15,184 shares. Largest reduction occurred in Q1 2026, reducing 12,343 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's AnaptysBio (ANAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly AnaptysBio (ANAB) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -12,343 | Reduce 71.33% | 4,962 | $55.46 |
| Q4 2025 | +3,436 | Add 24.77% | 17,305 | $48.48 |
| Q3 2025 | +4,450 | Add 47.24% | 13,869 | $30.62 |
| Q2 2025 | -775 | Reduce 7.60% | 9,419 | $22.20 |
| Q1 2025 | -168 | Reduce 1.62% | 10,194 | $18.59 |
| Q4 2024 | +382 | Add 3.83% | 10,362 | $13.24 |
| Q3 2024 | +9,980 | New Buy | 9,980 | $33.50 |
| Q1 2024 | -9,939 | Sold Out | 0 | $0.00 |
| Q4 2023 | +9,939 | New Buy | 9,939 | $21.42 |
| Q3 2023 | -10,307 | Sold Out | 0 | $0.00 |
| Q2 2023 | -4,877 | Reduce 32.12% | 10,307 | $20.34 |
| Q1 2023 | +15,184 | New Buy | 15,184 | $0.02 |
| Q1 2022 | -6,140 | Sold Out | 0 | $0.00 |
| Q4 2021 | +6,140 | New Buy | 6,140 | $34.69 |
| Q3 2021 | -10,902 | Sold Out | 0 | $0.00 |
| Q2 2021 | +10,902 | New Buy | 10,902 | $25.96 |
| Q1 2020 | -11,275 | Sold Out | 0 | $0.00 |
| Q4 2019 | +1,315 | Add 13.20% | 11,275 | $16.23 |
| Q3 2019 | +9,960 | New Buy | 9,960 | $35.04 |
Paul Tudor Jones's AnaptysBio Investment FAQs
Paul Tudor Jones first purchased AnaptysBio, Inc. (ANAB) in Q3 2019, acquiring 9,960 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held AnaptysBio, Inc. (ANAB) for 19 quarters since Q3 2019.
Paul Tudor Jones's largest addition to AnaptysBio, Inc. (ANAB) was in Q1 2023, adding 15,184 shares worth $330.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 4,962 shares of AnaptysBio, Inc. (ANAB), valued at approximately $275,193.
As of the Q1 2026 filing, AnaptysBio, Inc. (ANAB) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in AnaptysBio, Inc. (ANAB) was 17,305 shares, as reported at the end of Q4 2025.